Búsqueda | Portal de Búsqueda de la BVS España

1.

Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.

Altorki, Nasser; Wang, Xiaofei; Kozono, David; Watt, Colleen; Landrenau, Rodney; Wigle, Dennis; Port, Jeffrey; Jones, David R; Conti, Massimo; Ashrafi, Ahmad S; Liberman, Moishe; Yasufuku, Kazuhiro; Yang, Stephen; Mitchell, John D; Pass, Harvey; Keenan, Robert; Bauer, Thomas; Miller, Daniel; Kohman, Leslie J; Stinchcombe, Thomas E; Vokes, Everett.

N Engl J Med; 388(6): 489-498, 2023 02 09.

Artículo en Inglés | MEDLINE | ID: mdl-36780674

2.

The changing landscape of small cell lung cancer.

Cittolin-Santos, Giordano Fabricio; Knapp, Brendan; Ganesh, Bharath; Gao, Feng; Waqar, Saiama; Stinchcombe, Thomas Eldridge; Govindan, Ramaswamy; Morgensztern, Daniel.

Cancer; 2024 Mar 12.

Artículo en Inglés | MEDLINE | ID: mdl-38470453

3.

JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer.

Ramalingam, Suresh S; Thara, Eddie; Awad, Mark M; Dowlati, Afshin; Haque, Basir; Stinchcombe, Thomas E; Dy, Grace K; Spigel, David R; Lu, Sharon; Iyer Singh, Nithya; Tang, Yongqiang; Teslenko, Iryna; Iannotti, Nicholas.

Cancer; 128(1): 65-74, 2022 Jan 01.

Artículo en Inglés | MEDLINE | ID: mdl-34478166

4.

NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.

Rolfo, Christian; Drilon, Alexander; Hong, David; McCoach, Caroline; Dowlati, Afshin; Lin, Jessica J; Russo, Alessandro; Schram, Alison M; Liu, Stephen V; Nieva, Jorge J; Nguyen, Timmy; Eshaghian, Shahrooz; Morse, Michael; Gettinger, Scott; Mobayed, Mohammad; Goldberg, Sarah; Araujo-Mino, Emilio; Vidula, Neelima; Bardia, Aditya; Subramanian, Janakiraman; Sashital, Deepa; Stinchcombe, Thomas; Kiedrowski, Lesli; Price, Kristin; Gandara, David R.

Br J Cancer; 126(3): 514-520, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-34480094

5.

Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).

Wong, Melisa L; Gao, Junheng; Thanarajasingam, Gita; Sloan, Jeff A; Dueck, Amylou C; Novotny, Paul J; Jatoi, Aminah; Hurria, Arti; Walter, Louise C; Miaskowski, Christine; Cohen, Harvey J; Wood, William A; Feliciano, Josephine L; Stinchcombe, Thomas E; Wang, Xiaofei.

Oncologist; 26(3): e435-e444, 2021 03.

Artículo en Inglés | MEDLINE | ID: mdl-32951293

6.

Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. Reply.

Altorki, Nasser; Wang, Xiaofei; Stinchcombe, Thomas E.

N Engl J Med; 388(17): 1629-1630, 2023 Apr 27.

Artículo en Inglés | MEDLINE | ID: mdl-37099350

7.

Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.

Yang, Sen; Tang, Dongfang; Zhao, Yu Chen; Liu, Hongliang; Luo, Sheng; Stinchcombe, Thomas E; Glass, Carolyn; Su, Li; Shen, Sipeng; Christiani, David C; Wang, Qiming; Wei, Qingyi.

Cancer Immunol Immunother; 70(10): 2819-2833, 2021 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-33651148

8.

Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.

Yang, Sen; Tang, Dongfang; Zhao, Yu C; Liu, Hongliang; Luo, Sheng; Stinchcombe, Thomas E; Glass, Carolyn; Su, Li; Shen, Sipeng; Christiani, David C; Wang, Qiming; Wei, Qingyi.

Int J Cancer; 147(2): 392-403, 2020 07 15.

Artículo en Inglés | MEDLINE | ID: mdl-31618441

9.

A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.

Stinchcombe, Thomas E; Fan, Wen; Schild, Steven E; Vokes, Everett E; Bogart, Jeff; Le, Quynh-Thu; Thomas, Charles R; Edelman, Martin J; Horn, Leora; Komaki, Ritsuko; Cohen, Harvey J; Kishor Ganti, Apar; Pang, Herbert; Wang, Xiaofei.

Cancer; 125(3): 382-390, 2019 02 01.

Artículo en Inglés | MEDLINE | ID: mdl-30343497

10.

Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.

Xu, Yinghui; Liu, Hongliang; Liu, Shun; Wang, Yanru; Xie, Jichun; Stinchcombe, Thomas E; Su, Li; Zhang, Ruyang; Christiani, David C; Li, Wei; Wei, Qingyi.

Int J Cancer; 143(10): 2400-2408, 2018 11 15.

Artículo en Inglés | MEDLINE | ID: mdl-29978465

11.

Functional variants in DCAF4 associated with lung cancer risk in European populations.

Liu, Hongliang; Liu, Zhensheng; Wang, Yanru; Stinchcombe, Thomas E; Owzar, Kouros; Han, Younghun; Hung, Rayjean J; Brhane, Yonathan; McLaughlin, John; Brennan, Paul; Bickeböller, Heike; Rosenberger, Albert; Houlston, Richard S; Caporaso, Neil; Landi, Maria T; Brüske, Irene; Risch, Angela; Wu, Xifeng; Ye, Yuanqing; Christiani, David C; Amos, Christopher I; Wei, Qingyi.

Carcinogenesis; 38(5): 541-551, 2017 05 01.

Artículo en Inglés | MEDLINE | ID: mdl-28383684

12.

Current Treatments for Surgically Resectable, Limited-Stage, and Extensive-Stage Small Cell Lung Cancer.

Stinchcombe, Thomas E.

Oncologist; 22(12): 1510-1517, 2017 12.

Artículo en Inglés | MEDLINE | ID: mdl-28778960

13.

Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.

Wang, Xiaofei; Wang, Xiaoyi; Hodgson, Lydia; George, Stephen L; Sargent, Daniel J; Foster, Nate R; Ganti, Apar Kishor; Stinchcombe, Thomas E; Crawford, Jeffrey; Kratzke, Robert; Adjei, Alex A; Kindler, Hedy L; Vokes, Everett E; Pang, Herbert.

Oncologist; 22(2): 189-198, 2017 02.

Artículo en Inglés | MEDLINE | ID: mdl-28188257

14.

Targeted Therapies for Lung Cancer.

Stinchcombe, Thomas E.

Cancer Treat Res; 170: 165-82, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-27535394

15.

The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung Cancer.

Stinchcombe, Thomas E.

Curr Treat Options Oncol; 17(4): 18, 2016 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-26961971

16.

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.

Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet, Pierre-Jean; Baldini, Editta; Cappuzzo, Federico; Chouaid, Christos; Dowlati, Afshin; Sanborn, Rachel; Lopez-Chavez, Ariel; Grohe, Christian; Huber, Rudolf M; Harbison, Christopher T; Baudelet, Christine; Lestini, Brian J; Ramalingam, Suresh S.

Lancet Oncol; 16(3): 257-65, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25704439

17.

A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer.

Grilley-Olson, Juneko E; Keedy, Vicki L; Sandler, Alan; Moore, Dominic T; Socinski, Mark A; Stinchcombe, Thomas E.

Oncologist; 20(2): 105-6, 2015 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-25616430

18.

ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.

Chang, Joe Yujiao; Kestin, Larry L; Barriger, R Bryan; Chetty, Indrin J; Ginsburg, Mark E; Kumar, Sanath; Loo, Billy W; Movsas, Benjamin; Rimner, Andreas; Rosenzweig, Kenneth E; Stinchcombe, Thomas E; Videtic, Gregory M M; Willers, Henning.

Oncology (Williston Park); 28(8): 706-10, 712, 714 passim, 2014 Aug 15.

Artículo en Inglés | MEDLINE | ID: mdl-25140629

19.

Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.

Stinchcombe, Thomas E; Wang, Xiaofei; Damman, Bryce; Mentlick, Jennifer; Landreneau, Rodney; Wigle, Dennis; Jones, David R; Conti, Massimo; Ashrafi, Ahmad S; Liberman, Moishe; de Perrot, Marc; Mitchell, John D; Keenan, Robert; Bauer, Thomas; Miller, Daniel; Altorki, Nasser.

J Clin Oncol; 42(10): 1110-1113, 2024 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-38215351

20.

Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance).

Altorki, Nasser; Wang, Xiaofei; Damman, Bryce; Mentlick, Jennifer; Landreneau, Rodney; Wigle, Dennis; Jones, David R; Conti, Massimo; Ashrafi, Ahmad S; Liberman, Moishe; de Perrot, Marc; Mitchell, John D; Keenan, Robert; Bauer, Thomas; Miller, Daniel; Stinchcombe, Thomas E.

J Thorac Cardiovasc Surg; 167(1): 338-347.e1, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-37473998

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.

The changing landscape of small cell lung cancer.

JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer.

NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.

Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).

Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. Reply.

Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.

Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.

A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.

Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.

Functional variants in DCAF4 associated with lung cancer risk in European populations.

Current Treatments for Surgically Resectable, Limited-Stage, and Extensive-Stage Small Cell Lung Cancer.

Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.

Targeted Therapies for Lung Cancer.

The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung Cancer.

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.

A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer.

ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.

Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung Cancer.

Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance).